Authors: Vilner, BJ Bowen, WD

Citation: Bj. Vilner et Wd. Bowen, Modulation of cellular calcium by sigma-2 receptors: Release from intracellular stores in human SK-N-SH neuroblastoma cells, J PHARM EXP, 292(3), 2000, pp. 900-911

Authors: John, CS Bowen, WD Fisher, SJ Lim, BB Geyer, BC Vilner, BJ Wahl, RL

Citation: Cs. John et al., Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1 '-piperidinyl)ethyl]-3-[I-125]iodo-4-methoxybenzamide (P[I-125]MBA) for imaging breast cancer, NUCL MED BI, 26(4), 1999, pp. 377-382

Authors: Husbands, SM Izenwasser, S Kopajtic, T Bowen, WD Vilner, BJ Katz, JL Newman, AH

Citation: Sm. Husbands et al., Structure-activity relationships at the monoamine transporters and a receptors for a novel series of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)-propyl]carbazole (rimcazole) analogues, J MED CHEM, 42(21), 1999, pp. 4446-4455

Authors: John, CS Vilner, BJ Geyer, BC Moody, T Bowen, WD

Citation: Cs. John et al., Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors, CANCER RES, 59(18), 1999, pp. 4578-4583

Authors: Kedjouar, B Daunes, S Vilner, BJ Bowen, WD Klaebe, A Faye, JC Poirot, M

Citation: B. Kedjouar et al., Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor, BIOCH PHARM, 58(12), 1999, pp. 1927-1939